Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1459.5000 -11.40 (-0.78%)
NSE Jul 16, 2025 13:04 PM
Volume: 92,353
 

1459.50
-0.78%
Prabhudas Lilladhar
Q4FY22/Q1FY23. Domestic business (45% of total sales) continues to remain on strong footing and should continue to outperform IPM. Strong API capabilities and diversified model benefit IPCA in the current environment. We recommend Buy' rating on the stock with target price of Rs 2,450 based...
Ipca Laboratories Ltd. is trading above its 150 day SMA of 1451.3
More from Ipca Laboratories Ltd.
Recommended